Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yildiz Yardimci"'
Publikováno v:
15th Congress of the European Forum for Research in Rehabilitation (EFRR); 20190415-20190417; Berlin; DOC041 /20190416/
Background: In stroke patients, the prognosis of the upper extremity generally affects the daily living activities more. There are studies showing that kinesiotaping improved muscle function, supported joint structure, decreased pain and improved bod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fe5bf621f5dd856af94de45a17c0c07
Autor:
Umit Yasar, Atilla Bozkurt, Alpaslan Kilicarslan, Yildiz Yardimci, Melih O. Babaoglu, Gulay Sain-Guven
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 109:73-77
HMG-CoA reductase inhibitors (statins) have a potential to interact with substrates of the drug-metabolizing enzyme cytochrome P450 2C9 (CYP2C9). This may lead to concentration-dependent toxicity such as skeletal muscle side effects. Atorvastatin, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dc33f9d0003f74b99d8cb03a1f16e48
https://doi.org/10.1111/j.1742-7843.2011.00687.x
https://doi.org/10.1111/j.1742-7843.2011.00687.x
Autor:
Umit, Yasar, Gulay, Sain-Guven, Yildiz, Yardimci, Alpaslan, Kilicarslan, Melih O, Babaoglu, Atilla, Bozkurt
Publikováno v:
Basicclinical pharmacologytoxicology. 109(2)
HMG-CoA reductase inhibitors (statins) have a potential to interact with substrates of the drug-metabolizing enzyme cytochrome P450 2C9 (CYP2C9). This may lead to concentration-dependent toxicity such as skeletal muscle side effects. Atorvastatin, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb9ce44ad6218e8f48fd8360bfe24a21
https://pubmed.ncbi.nlm.nih.gov/21332946
https://pubmed.ncbi.nlm.nih.gov/21332946